Leslie L. Iversen, Director at ACADIA PHARMACEUTICALS INC (ACAD), bought 3,000 shares at $1.65 ($5K) on 2009-05-18, disclosed to the SEC on 2009-05-20.
Open-market purchase of $5k ACAD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2014-01-03 | $1.5M | — | Filing → |
| ACAD | SELL | 2013-09-13 | $1.4M | — | Filing → |